CC — The Chemours Company

Summary of The Chemours Company Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Net Sales: Met expectations, driven by record sales in the TSS segment, particularly from Opteon refrigerants.
• Free Cash Flow: Generated $92 million in Q4, reflecting strong cash generation potential.
• Adjusted EBITDA: Margins for TSS improved to 32%, up from 31% year-over-year.
• Earnings: Missed the low end of the earnings range due to noncash charges and inventory management strategies in the APM segment.

2. Strategic Updates and Business Highlights

• Kuan Yin Site Sale: Agreement to sell the Kuan Yin site expected to generate $300 million, aiding in debt reduction and lowering net leverage below three times by 2026.
• Leadership Changes: Welcomed Mike Foley as the new Business President of the Titanium Technologies (TT) segment.
• Operational Excellence: Achieved $125 million in gross controllable cost savings in 2025, with ongoing efforts to enhance productivity and reduce waste.
• TSS Segment Performance: Achieved record sales for Opteon refrigerants, with a 37% growth year-over-year, contributing to overall annual growth of 56%.
• APM Segment Recovery: Noted strengthening order books in semiconductor and data center materials, despite facing near-term headwinds.

3. Forward Guidance and Outlook

• Q1 2026 Expectations:
  • TSS net sales projected to rise by 20-30%, with adjusted EBITDA expected between $170 million and $185 million.
  • TT segment anticipates a sequential decline in net sales by low to mid-single digits, with adjusted EBITDA projected to be breakeven to $5 million.
  • APM expects a high-teens percentage decline in net sales due to market weakness and operational disruptions.
• Full Year 2026 Guidance:
  • Consolidated net sales growth expected between 3-5%, with adjusted EBITDA ranging from $800 million to $900 million.
  • Free cash flow conversion anticipated to exceed 25%, supported by improved earnings and working capital management.

4. Bad News, Challenges, or Points of Concern

• APM Segment Weakness: Faced challenges from cyclically sensitive end markets, particularly in auto and industrial construction, impacting earnings.
• Washington Works Facility Disruption: Temporary shutdown due to equipment issues affected capacity and is expected to have a $20-25 million negative impact in Q1.
• Inventory Management: Concerns raised about increasing inventory levels, which have risen significantly since 2019, indicating potential inefficiencies.
• Market Conditions: The TT segment is navigating a tepid global market, with volume seasonality affecting performance and uncertainty around antidumping duties in various regions.

5. Notable Q&A Insights

• TiO2 Volume Growth: Management indicated stable demand with no major triggers for growth, focusing on pricing power rather than volume increases.
• Legacy Liabilities: Progress noted in resolving legacy issues, particularly in New Jersey, with expectations for further updates throughout 2026.
• Customer Behavior: Residential HVAC customers are reducing production, leading to destocking, which could impact future sales.
• Antidumping Duties: Management expressed confidence in the benefits from antidumping actions in Brazil and Europe, while remaining cautious about the situation in India.

Overall, The Chemours Company demonstrated resilience in its financial performance, particularly in the TSS segment, while facing challenges in the APM and TT segments. The strategic focus on operational excellence and cash generation remains central to its outlook for 2026.